Leukapheresis in leukemia.
H E Mallard
Abstract
H E Mallard
Abstract
Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described. A case report of a 49-year-old female with a 13-year history of hairy cell leukemia who underwent intensive leukapheresis over seven months is given. Therapeutic cell depletions do not effect the eventual outcome of the disease but they do have a therapeutic role in the management of leukemia as a adjunct to other treatments.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described. A case report of a 49-year-old female with a 13-year history of hairy cell leukemia who underwent intensive leukapheresis over seven months is given. Therapeutic cell depletions do not effect the eventual outcome of the disease but they do have a therapeutic role in the management of leukemia as a adjunct to other treatments.
Key concepts: Leukapheresis, Leukostasis, Medicine, Leukocytosis, Leukemia, Acute leukemia, Intensive care medicine, Immunology